Career Development Program
职业发展计划
基本信息
- 批准号:8230262
- 负责人:
- 金额:$ 20.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Cancer Research ProjectClinicalClinical ManagementDevelopmentDiseaseDisorder by SiteFundingFutureGenitourinary systemGoalsHumanIncidenceIndividualInstructionLaboratoriesMalignant NeoplasmsMalignant neoplasm of urinary bladderMentorsMolecular and Cellular BiologyOncologistProtocols documentationRecruitment ActivityResearchResearch PersonnelResourcesScientistSeedsTrainingTranslatingTranslational ResearchUniversity of Texas M D Anderson Cancer CenterUrogenital Canceranticancer researchcancer therapycareercareer developmentcostdesignexperiencefallsinnovationinterestprogramsskills
项目摘要
Funding for bladder cancer (BC) research has fallen behind that provided for other malignancies. This is
especially the case for junior individuals. Therefore our SPORE In BC has provided one of the unique
resources for seed funding available to promising young laboratory and clinical scientists with a special
interest in pursuing independent translational research in BC. The overall goal of the Career Development
Program (CDP) is to support and mentor when appropriate the scientific careers of these individuals to
expand the number of such talented young invesfigators. Funding for bladder cancer focused research has
lagged behind support provided for other malignancies.
The specific aims of the CDP within this Bladder Cancer SPORE renewal builds on the strengths of our
current SPORE which included.
Recruiting innovafive entry-level and junior scientists into The University of Texas MD Anderson Cancer
Center Bladder Cancer SPORE to enhance its overall translational BC research capability.
Providing the opportunity for individuals with previous experience in the research and treatment of cancer
at other disease sites who wish to develop expertise in BC.
Promote the careers of the selected scientists by facilitating the development of skills necessary to be
productive independent investigators in BC translafional research.
Train clinical oncologists and basic scientists who can rapidly translate basic observations in cellular and
molecular biology into clinically applicable BC research programs and the design of protocols.
对膀胱癌(BC)研究的资助已经落后于对其他恶性肿瘤的资助。这是
尤其是对于年轻人来说。因此,我们在BC的孢子提供了一个独特的
种子基金资源提供给有前途的年轻实验室和临床科学家,
有兴趣在BC省进行独立的转化研究。职业发展的总体目标
项目(CDP)是在适当的时候支持和指导这些人的科学事业,
扩大这样有才华的年轻投资者的数量。为膀胱癌重点研究提供资金,
落后于为其他恶性肿瘤提供的支助。
CDP在膀胱癌孢子更新中的具体目标建立在我们的优势之上。
当前的SPORE包括。
招募创新入门级和初级科学家进入德克萨斯大学医学博士安德森癌症
中心膀胱癌孢子,以提高其整体翻译BC研究能力。
为具有癌症研究和治疗经验的个人提供机会
在其他疾病的网站谁希望发展专业知识在BC。
通过促进发展必要的技能,促进选定科学家的职业生涯,
在不列颠哥伦比亚省学术研究中富有成效的独立调查人员。
培训临床肿瘤学家和基础科学家,使他们能够迅速将基本观察结果转化为细胞和
将分子生物学应用于临床适用的BC研究计划和方案设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM Francis BENEDICT其他文献
WILLIAM Francis BENEDICT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM Francis BENEDICT', 18)}}的其他基金
Intravesical Gene Therapy for BCG Refractory Bladder Cancer
卡介苗难治性膀胱癌膀胱内基因治疗
- 批准号:
8230256 - 财政年份:2011
- 资助金额:
$ 20.32万 - 项目类别:
Improving Gene Therapy for Superficial Bladder Cancer
改善浅表性膀胱癌的基因治疗
- 批准号:
7729508 - 财政年份:2008
- 资助金额:
$ 20.32万 - 项目类别:
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death
RB4膀胱内基因治疗:细胞死亡机制
- 批准号:
7020047 - 财政年份:2003
- 资助金额:
$ 20.32万 - 项目类别:
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death
RB4膀胱内基因治疗:细胞死亡机制
- 批准号:
6612714 - 财政年份:2003
- 资助金额:
$ 20.32万 - 项目类别:
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death
RB4膀胱内基因治疗:细胞死亡机制
- 批准号:
7218605 - 财政年份:2003
- 资助金额:
$ 20.32万 - 项目类别:
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death
RB4膀胱内基因治疗:细胞死亡机制
- 批准号:
6881558 - 财政年份:2003
- 资助金额:
$ 20.32万 - 项目类别:
RB4 Intravesical Gene Therapy: Mechanisms of Cell Death
RB4膀胱内基因治疗:细胞死亡机制
- 批准号:
6721446 - 财政年份:2003
- 资助金额:
$ 20.32万 - 项目类别:
BIOCHEMICAL AND CYTOGENETIC MARKERS IN RETINOBLASTOMA
视网膜母细胞瘤的生化和细胞遗传学标志物
- 批准号:
2683511 - 财政年份:1991
- 资助金额:
$ 20.32万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Physical activity and the clinical management of chronic diseases in children
体力活动与儿童慢性病的临床管理
- 批准号:
495569 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Operating Grants
Transforming Parkinson's disease clinical management with integrated digital health technologies
利用集成数字健康技术改变帕金森病临床管理
- 批准号:
EP/W031590/2 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Research Grant
Optimizing the Clinical Management of Polypharmacy for Children with Medical Complexity
优化医疗复杂性儿童多重用药的临床管理
- 批准号:
10656034 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Transforming Parkinson's disease clinical management with integrated digital health technologies
利用集成数字健康技术改变帕金森病临床管理
- 批准号:
EP/W031590/1 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Research Grant
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
改善乳糜泻临床管理的新技术评估:GLUTECH 试验
- 批准号:
10718458 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Non-Contact Solution for Quantitative Clinical Management of MTD
MTD 定量临床管理的非接触式解决方案
- 批准号:
10256594 - 财政年份:2022
- 资助金额:
$ 20.32万 - 项目类别:
AI-Based Identification of Rapid Glaucoma Progression to Guide Clinical Management and Accelerate Clinical Trials
基于人工智能的青光眼快速进展识别,指导临床管理并加速临床试验
- 批准号:
10553060 - 财政年份:2022
- 资助金额:
$ 20.32万 - 项目类别:
DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder
利用大数据模拟 DAT 目标试验,加强阿片类药物使用障碍临床管理的证据基础
- 批准号:
10551310 - 财政年份:2021
- 资助金额:
$ 20.32万 - 项目类别:
Ambulatory monitoring of a vocal efficiency index to improve the clinical management of voice disorders
动态监测发声效率指数以改善发声障碍的临床管理
- 批准号:
10629293 - 财政年份:2021
- 资助金额:
$ 20.32万 - 项目类别:
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease
改善乳糜泻临床管理的新技术评价
- 批准号:
10482373 - 财政年份:2021
- 资助金额:
$ 20.32万 - 项目类别: